Skip to content
Simpler Grants

No. HT942526OCRPOCCTAECI · Defense Health Agency Contracting Activity - DHACA

Open

DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“full application submission is by invitation only.” — From the announcement
Award range
Not specified
Expected awards
~3
Application deadline
Oct 1, 2026 29 days left
Posted
May 4, 2026
Last verified
2 days ago

At a glance

AI summary

The Ovarian Cancer Research Program is funding several awards for ovarian cancer research, including clinical trials, investigator-initiated research, early-career academy awards, and pilot projects. Eligible applicants range from postdoctoral or clinical fellows to independent investigators and assistant professors or higher, depending on the mechanism; the early-career academy awards require applicants to be within a set number of years of their last postdoctoral or fellowship position and to have a mentor. Award sizes and periods range from up to $350,000 total costs over 2 years for Pilot Awards to up to $2.8 million total costs over 4 years for the Clinical Trial Award, with other awards capped between $1.05 million and $1.4 million over 4 years. Some mechanisms require preliminary data, some do not allow clinical trials, and several require a letter of intent or preproposal before full application. The notice does not state any geographic or set-aside restrictions.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Training, Fellowship & Career Development
  • Patients & People with Health Conditions
  • Researchers & Scholars
  • Biomedical & Disease Research
Official description from grants.gov

Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under this FY26 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer. Preliminary data are required, however, these data do not necessarily need to be derived from the ovarian cancer research field. The ECI must be within 12 years of their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent at the time of full application submission deadline. The ECI must commit no less than 25% effort to this award and/or OCCTA activities for the first two years. The Designated Mentor must be a clinical trialist with a strong record of mentoring and training early-career investigators.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097
FY 2023 1,115
FY 2022 1,186
FY 2021 1,023

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026